Skip to main content

Breadcrumb

  1. Home

Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Atlas of Transcription Factor Binding Sites from ENCODE DNase Hypersensitivity Data across 27 Tissue Types

Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Successful treatment with enasidenib, bortezomib, and dexamethasone for the synchronous occurrence of IDH2-positive acute myeloid leukemia and multiple myeloma

Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Mendelian randomization identifies FLCN expression as a mediator of diabetic retinopathy

Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Circulating tumor DNA genomics reveal potential mechanisms of resistance to BRAF-targeted therapies in patients with BRAF-mutant metastatic non–small cell lung cancer

Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Real-world PD-L1 test utilization and analytical concordance of the PD-L1 IHC 28-8 and 22C3 assays in patients with breast cancer

Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Early plasma circulating tumor DNA (ctDNA) changes predict response to first-line pembrolizumab-based therapy in non-small cell lung cancer (NSCLC)

NTRK Fusions and Trk Proteins: What are They and How to Test for Them

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about NTRK Fusions and Trk Proteins: What are They and How to Test for Them

A solid variant of splenic mesothelial cyst, a case report with molecular analysis

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about A solid variant of splenic mesothelial cyst, a case report with molecular analysis

Radiogenomic analysis of locally advanced lung cancer based on CT imaging and intratreatment changes in cell-free DNA

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Radiogenomic analysis of locally advanced lung cancer based on CT imaging and intratreatment changes in cell-free DNA

Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma

Submitted by Anonymous (not verified) on Mon, 12/23/2024 - 06:53
  • Read more about Longitudinal Circulating Tumor DNA Analysis in Blood and Saliva for Prediction of Response to Osimertinib and Disease Progression in EGFR-Mutant Lung Adenocarcinoma

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 80
  • Page 81
  • Page 82
  • Page 83
  • Page 84
  • Page 85
  • Page 86
  • Page 87
  • Page 88
  • …
  • Next page Next
  • Last page Last
Subscribe to